Literature DB >> 11081190

Leptin after IGF-I generation test in a patient with hypopituitarism and myotonic dystrophy disease.

J M Gómez1, J A Martínez-Matos.   

Abstract

A 54-years-old woman diagnosed of myotonic dystrophy (MyD) with past medical history of massive postpartum haemorrhage at age 28 and panhypopituitarism was studied. BMI and body composition were determined and we determined baseline serum IGF-I, IGFBP3, insulin and leptin levels and after the IGF-I generation test performed after the GH administration of 0.1 U/kg/day s.c each evening for 4 days. As expected the patient had lower baseline IGF-I and IGFBP3 with high insulin and leptin levels. After IGF-I generation test, IGF-I, IGFBP3 and insulin levels increases without changes in body composition and leptin levels. In the current study, high leptin baseline levels may reflect the hyperinsulinism action over the adipose tissue in MyD and the effect of hypopituitarism over leptin regulation. After 4 days of GH administration, we demonstrated the lack of a modulatory role on leptin levels of GH and acute insulin increase, and a direct effect of GH on leptin can be excluded.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11081190     DOI: 10.1023/a:1009984505312

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  16 in total

Review 1.  Leptin: the tale of an obesity gene.

Authors:  J F Caro; M K Sinha; J W Kolaczynski; P L Zhang; R V Considine
Journal:  Diabetes       Date:  1996-11       Impact factor: 9.461

2.  Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects.

Authors:  M S Gill; A A Toogood; P A O'Neill; J E Adams; M O Thorner; S M Shalet; P E Clayton
Journal:  Clin Endocrinol (Oxf)       Date:  1997-08       Impact factor: 3.478

3.  Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment.

Authors:  F Nyström; B Ekman; M Osterlund; T Lindström; K P Ohman; H J Arnqvist
Journal:  Clin Endocrinol (Oxf)       Date:  1997-08       Impact factor: 3.478

4.  Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro.

Authors:  J W Kolaczynski; M R Nyce; R V Considine; G Boden; J J Nolan; R Henry; S R Mudaliar; J Olefsky; J F Caro
Journal:  Diabetes       Date:  1996-05       Impact factor: 9.461

5.  UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.

Authors:  A Widjaja; I M Stratton; R Horn; R R Holman; R Turner; G Brabant
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

6.  Insulin regulation of leptin synthesis and secretion in humans: the model of myotonic dystrophy.

Authors:  J M Gómez; A Molina; M Fernández-Castañer; R Casamitjana; J A Martínez-Matos; J Soler
Journal:  Clin Endocrinol (Oxf)       Date:  1999-05       Impact factor: 3.478

7.  The circadian rhythm of leptin is preserved in growth hormone deficient hypopituitary adults.

Authors:  E Kousta; A Chrisoulidou; N J Lawrence; K A al-Shoumer; K H Parker; M I McCarthy; D G Johnston
Journal:  Clin Endocrinol (Oxf)       Date:  1998-06       Impact factor: 3.478

8.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

9.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

10.  GH secretion status in myotonic dystrophy.

Authors:  J M Gómez-Sáez; J M Fernández-Real; M A Navarro; J A Martínez-Matos; J Soler
Journal:  Psychoneuroendocrinology       Date:  1993       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.